AU Patent

AU2007237096C1 — Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof

Assigned to Eyepoint Pharmaceuticals Inc · Expires 2012-12-13 · 13y expired

What this patent protects

Antibodies and antigen binding fragments thereof that bind to human protein tyrosine phosphatase beta (HPTPβ), and uses thereof.

USPTO Abstract

Antibodies and antigen binding fragments thereof that bind to human protein tyrosine phosphatase beta (HPTPβ), and uses thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2007237096C1
Jurisdiction
AU
Classification
—
Expires
2012-12-13
Drug substance claim
No
Drug product claim
No
Assignee
Eyepoint Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.